Cite
A monoclonal antibody ameliorates local inflammation and osteoporosis by targeting TNF-α and RANKL.
MLA
Qian, Hongyan, et al. “A Monoclonal Antibody Ameliorates Local Inflammation and Osteoporosis by Targeting TNF-α and RANKL.” International Immunopharmacology, vol. 20, no. 2, June 2014, pp. 370–76. EBSCOhost, https://doi.org/10.1016/j.intimp.2014.03.017.
APA
Qian, H., Yuan, H., Wang, J., Du, Y., Zhang, X., Sun, Y., Li, Z., & Zhao, W. (2014). A monoclonal antibody ameliorates local inflammation and osteoporosis by targeting TNF-α and RANKL. International Immunopharmacology, 20(2), 370–376. https://doi.org/10.1016/j.intimp.2014.03.017
Chicago
Qian, Hongyan, Huihui Yuan, Jun Wang, Yuxuan Du, Xulong Zhang, Ying Sun, Zhanguo Li, and Wenming Zhao. 2014. “A Monoclonal Antibody Ameliorates Local Inflammation and Osteoporosis by Targeting TNF-α and RANKL.” International Immunopharmacology 20 (2): 370–76. doi:10.1016/j.intimp.2014.03.017.